-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Autolus Therapeutics plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2017 to Q2 2024.
- Autolus Therapeutics plc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $51K, a 27.5% increase year-over-year.
- Autolus Therapeutics plc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$2.5K, a 101% decline year-over-year.
- Autolus Therapeutics plc annual Income Tax Expense (Benefit) for 2023 was -$19.5K, a 107% decline from 2022.
- Autolus Therapeutics plc annual Income Tax Expense (Benefit) for 2022 was $272K, a 369% increase from 2021.
- Autolus Therapeutics plc annual Income Tax Expense (Benefit) for 2021 was $58K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)